反応式
Cl.[F:2][C:3]1[CH:4]=[C:5]([C@H:10]2[CH2:14][CH2:13][CH2:12][NH:11]2)[CH:6]=[C:7]([F:9])[CH:8]=1.Br[C:16]1[CH:21]=[CH:20][N:19]2[N:22]=[CH:23][C:24]([C:25]([O:27]CC)=[O:26])=[C:18]2[CH:17]=1>>[F:9][C:7]1[CH:6]=[C:5]([C@H:10]2[CH2:14][CH2:13][CH2:12][N:11]2[C:16]2[CH:21]=[CH:20][N:19]3[N:22]=[CH:23][C:24]([C:25]([OH:27])=[O:26])=[C:18]3[CH:17]=2)[CH:4]=[C:3]([F:2])[CH:8]=1参加物
3
実験手順
The title compound was prepared by a method substantially similar to that mentioned in step-5 and step-6 of example-3 using (R)-2-(3,5-Difluorophenyl)pyrrolidine hydrochloride (step-1) and Ethyl 5-bromo-pyrazolo[1,5-a]pyridine-3-carboxylate to afford the product as white solid. MS (ESI): m/z 344.1 (M+H).
出典と根拠
- ORDレコード
- ord-4a066e0542bd4a43b259a669fb1a787f
- 出典データセット
- uspto-grants-2015_06
- 特許番号
- US09045479B2
関連ノート
読み込み中…